Details for Patent: 8,815,889
✉ Email this page to a colleague
Which drugs does patent 8,815,889 protect, and when does it expire?
Patent 8,815,889 protects CONTRAVE and is included in one NDA.
This patent has twenty-seven patent family members in fourteen countries.
Summary for Patent: 8,815,889
| Title: | Compositions and methods for increasing insulin sensitivity |
| Abstract: | Methods and compositions for treating a blood glucose condition involve identifying a suitable subject and administering an effective amount of a composition that contains one or more of an opioid antagonist, an anticonvulsant, and a psychotherapeutic agent. The compositions can include insulin. In some embodiments, such methods and compositions can be used to modulate a blood glucose level. In preferred embodiments, such methods and compositions are useful for increasing a subject's sensitivity to insulin. |
| Inventor(s): | Cowley; Michael A. (Portland, OR), McKinney; Anthony A. (San Diego, CA), Tollefson; Gary (Indianapolis, IN) |
| Assignee: | Orexigen Therapeutics, Inc. (San Diego, CA) |
| Application Number: | 11/602,571 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,815,889 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Dosage form; |
Drugs Protected by US Patent 8,815,889
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nalpropion | CONTRAVE | bupropion hydrochloride; naltrexone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 200063-001 | Sep 10, 2014 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | FOR EFFECT ON BLOOD GLUCOSE PARAMETERS IN PATIENTS WITH INSULIN RESISTANCE | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,815,889
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 057631 | ⤷ Try a Trial | |||
| Australia | 2006323048 | ⤷ Try a Trial | |||
| Brazil | PI0618918 | ⤷ Try a Trial | |||
| Canada | 2630624 | ⤷ Try a Trial | |||
| China | 101370488 | ⤷ Try a Trial | |||
| Denmark | 2135603 | ⤷ Try a Trial | |||
| European Patent Office | 1951212 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
